Abstract
Angioedema without wheals (urticaria) represents a heterogeneous group of clinically indistinguishable diseases of hereditary or acquired etiology. Hereditary angioedema (HAE) is a rare inherited condition leading to recurrent, sometimes life-threatening angioedema attacks in subcutaneous tissues, gastrointestinal and oropharyngeal mucosa dating back to childhood or adolescence. Most of these patients have mutations in the SERPING1 gene, causing either low C1-Inhibitor (C1-INH) production (HAE-C1-INH type I) or the production of dysfunctional C1-INH (HAE-C1-INH type II). HAE with normal C1 inhibitor (HAE-nC1-INH) has been defined later. Although C1-INH concentration and function are in the normal range, it leads to typical HAE symptoms due to mutations in FXII, Plasminogen, Angiopoietin1, Kininogen1, and myoferlin genes. Patients who exhibit none of these genetic mutations despite having a similar clinical presentation are classified as HAE-Unknown. Fewer than 1 in 10 patients with C1-INH deficiency have acquired angioedema with C1-INH deficiency (AAE-C1-INH). The clinical presentation is very similar to HAE, making it difficult to distinguish these two conditions clinically. Unlike HAE, there are no genetic mutations, and family history and symptoms tend to appear later in life. AAE-C1-INH is commonly associated with lymphoproliferative and autoimmune diseases. Angioedema attacks might start one year before the underlying disease in AAE-C1-INH. Approximately half of the patients admitted to the hospital for acute angioedema are patients receiving ACE inhibitor therapy. Angioedema typically occurs in the lips, tongue, mouth, pharynx, and subglottic regions. Patients may require hospitalization and intensive care monitoring due to airway involvement. Idiopathic histaminergic angioedema (AAE-IH) may be diagnosed only when any possible causes of histaminergic angioedema are excluded (foods, drugs, animal dander, aeroallergens, insects stings, latex, e.g.), and the symptoms respond well to antihistamine treatment. Idiopathic non-histaminergic acquired angioedema (AAE-InH) should be considered when all other types of recurrent angioedema have been ruled out and patients do not respond to high-dose antihistamines. The lack of a standard biochemical laboratory test for patients with AAE-IH, AAE-InH, AAE-ACEI, and HAE-nC1-INH makes the diagnosis more challenging. Future efforts should focus on increasing awareness of all rare types of angioedema among physicians and developing more straightforward and more accessible diagnostic methods.

This publication has 69 references indexed in Scilit: